IP Library Granted Patent US 9,084,773
Granted Patent B2
US 9,084,773 · App. 14/288,984 · Granted Jul 21, 2015

Small molecule antagonists of bacterial quorum-sensing receptors

Inventors: Bonnie L. Bassler (Princeton, NJ); Lee R. Swem (Montara, CA); Scott M. Ulrich (Ithaca, NY); Colleen T. O'Loughlin (Princeton, NJ)
Assignee: The Trustees of Princeton University
A61K31/365A01N43/08A01N43/10A01N43/16A01N43/18A61K31/341A61K31/381C07D307/33C07D333/36
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,084,773
App. No.
14/288,984
Granted
Jul 21, 2015
Kind
B2
Abstract

A novel small molecule antagonizes two types of acyl homoserine lactone receptors: membrane-bound and cytoplasmic. A focused library of analogs and derivatives of the original antagonist was synthesized. Analog and derivative molecules harbor a range of activities. The novel small molecule and most potent antagonist protects the eukaryote Caenorhabditis elegans from quorum-sensing-mediated killing by the bacterial pathogen Chromobacterium violaceum . The saving of C. elegans demonstrates the use of these molecules as small molecule antimicrobials.

Claims (12)

1. A small molecule analog of 4-(4-chloro-2-methylphenoxy)-N-(2-oxotetrahydrothiophen-3-yl)butanamide wherein said small molecule is represented by the formula:

wherein X is O or S; n is 0, 1 or 2; Y is O, S or CH 2 ; and Z is a halogen, hydroxyl, alkoxyl, cyano, nitro, amido, acetamido, amino, alkylamino, aryl, heteroaryl, acyl, alkyl, cycloalkyl, sulfonamide, alkyl sulfonamide or a combination thereof; and

wherein Z is located at the ortho, meta or para position or at a combination thereof.

2. The molecule of claim 1 that is

3. The molecule of claim 1 that is CTL.

4. The molecule of claim 1 that is CL.

5. The molecule of claim 1 that is o-fluoro-chloro-lactone.

6. The molecule of claim 1 that is m-fluoro-chloro-lactone.

7. A method of controlling growth of quorum-sensing bacteria attached to a solid surface comprising exposing the bacteria to a bacterial biofilm-inhibiting composition comprising the molecule of claim 2 .

8. A method of preventing biofilm formation on a solid surface comprising administering to the surface a bacterial biofilm-inhibiting composition comprising the molecule of claim 2 .

9. A method of inhibiting quorum sensing-mediated activity in bacteria comprising contacting the bacteria with the molecule of claim 2 , wherein the activity is production of virulence factors.

10. The method of claim 9 wherein the bacterial species is selected from the group consisting of V. harveyi, C. violaceum and P. aeruginosa.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 5, 2016
From: BASSLER, BONNIE; SWEM, LEE; ULRICH, SCOTT; O'LOUGHLIN, COLLEEN
To: THE TRUSTEES OF PRINCETON UNIVERSITY
Reel/Frame 038475/0436 →
CONFIRMATORY LICENSE Recorded Jun 19, 2015
From: PRINCETON UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 035932/0426 →
Continuity (5)
Continuation 13550961 · Jul 17, 2012
Continuation 12643574 · Dec 21, 2009
Provisional Application 61203371 · Dec 22, 2008
Provisional Application 61270979 · Jul 15, 2009
Related Publication 20140275232A1 · Sep 18, 2014